Company / CapEx per Share
Avidity Biosciences, Inc. CapEx per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.10
FY2025
5-year range
$0.05 / $0.10
FY2021-FY2025
Trend
+52.7%
vs FY2024
Sector context
#58 of 192
Health Care
What the data says
At $0.10, Avidity Biosciences, Inc.'s capex per share ranks #58 of 192 in the Health Care sector. CapEx per Share has increased for 3 consecutive years, from $0.05 in FY2022 to $0.10 in FY2025.
Based on SEC 10-K filings.
0.10 in FY2025 with a 5-year CAGR of +13.9%.
Improved from $0.06 to $0.10 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +21.4%
- 5-Year CAGR
- +13.9%
- 10-Year CAGR
- -
Sector benchmark
#58 of 192 in Health CareTop 30% of 192This company $0.10 Sector average $3.54
▼
-97.3% below sector average
Key checks
Key Insights
- Avidity Biosciences, Inc.'s capex per share has grown for 3 consecutive years.
- In FY2025, capex per share increased 52.7% year-over-year.
- Ranks #58 out of 192 companies in the Health Care sector.
- Lowest capex per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | +52.7% |
| FY2024 | $0.06 | +9.4% |
| FY2023 | $0.06 | +7.0% |
| FY2022 | $0.05 | -40.1% |
| FY2021 | $0.09 | +79.1% |
| FY2020 | $0.05 | -41.8% |
| FY2019 | $0.09 | +337.9% |
| FY2018 | $0.02 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026